0832 GMT - European pharmaceutical sector corporate bonds are likely to stay resilient in the face of tariff threats, Goldman Sachs credit strategists say in a note. Credit spreads on euro-denominated investment-grade pharma bonds have been relatively stable despite the increased risk of U.S. tariffs on the sector. "We expect tariff risks to put a floor on the relative pricing of the sector versus the broader market, but further material underperformance is unlikely," they say. (miriam.mukuru@wsj.com)

(END) Dow Jones Newswires

July 18, 2025 04:32 ET (08:32 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.